ATE553780T1 - Ph-sensitives polymer - Google Patents

Ph-sensitives polymer

Info

Publication number: ATE553780T1
Authority: AT; Austria
Prior art keywords: sensitive polymer; cytotoxic; carriers; natural; active pharmaceutical
Prior art date: 2002-04-30

Application number

AT02785268T

Other languages

English (en)

Inventor

Hans-Ulrich Petereit

Christian Meier

Klaus Schultes

Marie-Andree Yessine

Jean-Christophe Leroux

Original Assignee

Evonik Roehm Gmbh

Univ Montreal

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-30

Filing date

2002-10-22

Publication date

2012-05-15

2002-10-22 Application filed by Evonik Roehm Gmbh, Univ Montreal filed Critical Evonik Roehm Gmbh

2012-05-15 Application granted granted Critical

2012-05-15 Publication of ATE553780T1 publication Critical patent/ATE553780T1/de

Links

229920000642 polymer Polymers 0.000 title abstract 3
239000008186 active pharmaceutical agent Substances 0.000 abstract 1
239000000969 carrier Substances 0.000 abstract 1
231100000433 cytotoxic Toxicity 0.000 abstract 1
230000001472 cytotoxic effect Effects 0.000 abstract 1
230000001576 membenolytic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/04—Acids; Metal salts or ammonium salts thereof
- C08F220/06—Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/42—Nitriles
- C08F220/44—Acrylonitrile
- C08F220/46—Acrylonitrile with carboxylic acids, sulfonic acids or salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Immunology (AREA)
Neurology (AREA)
Communicable Diseases (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Oncology (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Physical Education & Sports Medicine (AREA)
Inorganic Chemistry (AREA)
Rheumatology (AREA)
Biotechnology (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Polymers & Plastics (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Hospice & Palliative Care (AREA)

AT02785268T 2002-04-30 2002-10-22 Ph-sensitives polymer ATE553780T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10219505		2002-04-30
DE10220470A DE10220470A1 (de)	2002-04-30	2002-05-07	ph-sensitives Polymer
PCT/EP2002/011791 WO2003092732A1 (en)	2002-04-30	2002-10-22	Ph-sensitive polymer

Publications (1)

Publication Number	Publication Date
ATE553780T1 true ATE553780T1 (de)	2012-05-15

Family

ID=29403572

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02785268T ATE553780T1 (de)	2002-04-30	2002-10-22	Ph-sensitives polymer

Country Status (12)

Country	Link
US (2)	US7553918B2 (de)
EP (1)	EP1499358B1 (de)
JP (1)	JP5021160B2 (de)
KR (1)	KR20050025164A (de)
AT (1)	ATE553780T1 (de)
AU (1)	AU2002350592A1 (de)
BR (1)	BRPI0215731B8 (de)
CA (1)	CA2480273C (de)
DE (1)	DE10220470A1 (de)
ES (1)	ES2386422T3 (de)
IL (2)	IL163584A0 (de)
WO (1)	WO2003092732A1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10220470A1 (de)	2002-04-30	2003-11-20	Roehm Gmbh	ph-sensitives Polymer
DE19961334A1 (de) *	1999-12-17	2001-06-21	Roehm Gmbh	Spritzgußverfahren für neutrale und säuregruppenhaltige (Meth)acrylat-Copolymere
DE10127134A1 (de) *	2001-06-05	2002-12-12	Roehm Gmbh	verfahren zur Herstellung von Formkörpern aus (Meth)acrylat-Copolymeren mittels Spritzguß
DE10208335A1 (de) *	2002-02-27	2003-09-04	Roehm Gmbh	Arzneiform und Verfahren zu ihrer Herstellung
DE10214002A1 (de) *	2002-03-27	2003-10-09	Roehm Gmbh	Pharmazeutische Formulierung für den Wirkstoff Budesonid
DE10250543A1 (de) *	2002-10-29	2004-05-19	Röhm GmbH & Co. KG	Mehrschichtige Arzneiform
MXPA04010956A (es) *	2003-01-30	2005-01-25	Roehm Gmbh	Forma de dosis farmaceutica y metodo para la produccion de la misma.
DE10320318A1 (de) *	2003-05-06	2004-12-02	Röhm GmbH & Co. KG	Verfahren zur Herstellung von lichtstreuenden Formteilen mit hervorragenden optischen Eigenschaften
DE10345045A1 (de) *	2003-09-26	2005-04-14	Röhm GmbH & Co. KG	Verfahren zur Oberflächenvergütung von Werkstoffen durch Aufbringen insbesondere transparenter Schichten auf Basis von Polymethacrylaten
MX2007008855A (es) *	2003-10-18	2008-03-13	Roehm Gmbh	Masas de pieza moldeada de poli (met) acrilato resistentes a impactos con alta estabilidad termica.
US20070224274A1 (en) *	2004-04-05	2007-09-27	Werner Siol	Polymer Particles Containing Active Agents
DE102004022540A1 (de)	2004-05-05	2005-12-08	Röhm GmbH & Co. KG	Formmasse für Formkörper mit hoher Witterungsbeständigkeit
DE102004045296A1 (de) *	2004-09-16	2006-03-23	Röhm GmbH & Co. KG	Verwendung von Polyalkyl (meth) acrylat-Perlpolymerisaten und Formmasse zur Herstellung von extrudierten Formteilen mit mattierter Oberfläche
US9011831B2 (en)	2004-09-30	2015-04-21	Advanced Cardiovascular Systems, Inc.	Methacrylate copolymers for medical devices
DE102004058083A1 (de) *	2004-12-01	2006-06-08	Röhm GmbH & Co. KG	Gedeckt eingefärbte, infrarotreflektierende Kunststoffformmasse
DE102005007059A1 (de) *	2005-02-15	2006-08-24	Röhm GmbH & Co. KG	Teilneutralisiertes anionisches (Meth)acrylat-Copolymer
DE102005021335A1 (de) *	2005-05-04	2006-11-09	Röhm Gmbh	Verfahren zur Herstellung von Perlpolymerisaten mit einer mittleren Teilchengröße im Bereich von 1 µm bis 40 µm sowie Perlpolymerisat aufweisende Formmassen und Formkörper
KR100720339B1 (ko) *	2005-09-15	2007-05-22	삼성전자주식회사	영상처리장치
DE102005055793A1 (de)	2005-11-21	2007-05-24	Röhm Gmbh	Transparente TPU (thermoplastische Polyurethane)/ PMMA (Polymethyl(meth)acrylat) Abmischungen mit verbesserter Kältesschlagzähigkeit
DE102006029613A1 (de)	2006-06-26	2007-12-27	Röhm Gmbh	Transparenter Kunststoff-Verbund
US7932218B2 (en)	2006-07-31	2011-04-26	Ciba Corporation	Lubricant composition
DE102007005432A1 (de) *	2007-01-30	2008-07-31	Evonik Röhm Gmbh	Formmassen für mattierte Polyacrylat-Formkörper
DE102007005428A1 (de) *	2007-01-30	2008-07-31	Evonik Röhm Gmbh	Formmassen für mattierte PMMI-Formkörper
DE102007026200A1 (de) *	2007-06-04	2008-12-11	Evonik Röhm Gmbh	Zusammensetzung mit erhöhter Spannungsrissbeständigkeit
DE102007026201A1 (de) *	2007-06-04	2008-12-11	Evonik Röhm Gmbh	Eingefärbte Zusammensetzung mit erhöhter Spannungsrissbeständigkeit
DE102007028601A1 (de) *	2007-06-19	2008-12-24	Evonik Röhm Gmbh	Reaktivgemisch zur Beschichtung von Formkörpern mittels Reaktionsspritzguss sowie beschichteter Formkörper
DE102007029263A1 (de) *	2007-06-22	2008-12-24	Evonik Röhm Gmbh	PMMA/PVDF-Folie mit besonders hoher Witterungsbeständigkeit und hoher UV-Schutzwirkung
DE102007051482A1 (de)	2007-10-25	2009-04-30	Evonik Röhm Gmbh	Verfahren zur Herstellung von beschichteten Formkörpern
DE102007059632A1 (de) *	2007-12-10	2009-06-18	Evonik Röhm Gmbh	Formkörper mit matter und strukturierter Oberflächenbeschaffenheit
DE102008001231A1 (de) *	2008-04-17	2009-10-22	Evonik Röhm Gmbh	Flammfeste PMMA-Formmasse
DE102008001695A1 (de)	2008-05-09	2009-11-12	Evonik Röhm Gmbh	Poly(meth)acrylimide mit verbesserten optischen und Farbeigenschaften, insbesondere bei thermischer Belastung
ES2404136T3 (es)	2008-05-13	2013-05-24	University Of Washington	Ensamblajes micelares
GB201005652D0 (en) *	2010-04-06	2010-05-19	Eastman Kodak Co	Stimulus-responsive poiymeric particles
KR101830465B1 (ko)	2010-12-02	2018-02-20	디에스엠 아이피 어셋츠 비.브이.	아크릴계 중합체
CN103501768B (zh) *	2011-06-17	2016-11-09	赢创罗姆有限公司	具有抗乙醇影响抗性的抗胃酸的药物或营养组合物
RU2015115649A (ru)	2012-09-27	2016-11-20	Октафарма Аг	Тест на гемолитический потенциал фармацевтических продуктов и составов для минимизации риска
AU2014296278C1 (en)	2013-07-30	2023-02-02	Genevant Sciences Gmbh	Block copolymers and their conjugates or complexes with oligonucleotides
CN114642735A (zh)	2015-01-21	2022-06-21	菲泽尔克斯公司	用于将治疗剂和诊断剂递送到细胞中的方法、组合物和系统
JP6722908B2 (ja) *	2016-04-18	2020-07-15	学校法人福岡大学	タンパク質吸着材
JP6912876B2 (ja) *	2016-10-06	2021-08-04	三洋化成工業株式会社	アクリル系医薬固形製剤用添加剤
US11684584B2 (en)	2016-12-30	2023-06-27	Genevant Sciences Gmbh	Branched peg molecules and related compositions and methods
US11717325B2 (en) *	2017-12-03	2023-08-08	Nasser Kamal Abd Elaal	Medicated uterine balloon with cervical barricade for management of postpartum hemorrhage
DE102017130893A1 (de) *	2017-12-21	2019-06-27	Paul Hartmann Ag	pH regulierende Wundauflage
EP3921418A4 (de)	2019-02-06	2023-02-08	Singular Genomics Systems, Inc.	Zusammensetzungen und verfahren zur nukleinsäuresequenzierung
DE102020002360A1 (de)	2020-04-18	2021-10-21	Friedrich-Schiller-Universität Jena	Nanopartikel enthaltend Komplexe aus Nukleinsäuren und kationischen Copolymeren, Verfahren zu deren Herstellung und deren Verwendung zum Gentransfer in Zellen
EP4423664A4 (de)	2021-10-25	2025-08-27	Singular Genomics Systems Inc	Manipulation und detektion biologischer proben

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0164669B1 (de) *	1984-06-13	1991-01-23	Röhm Gmbh	Verfahren zum Überziehen von Arzneiformen
JP2748013B2 (ja)	1989-03-16	1998-05-06	三菱レイヨン株式会社	粉末状アクリル樹脂の製造方法
DE4026992A1 (de) *	1990-08-25	1992-02-27	Roehm Gmbh	Verfahren zur herstellung von traegersystemen fuer biologisch aktive materialien
DE4310012A1 (de) *	1993-03-27	1994-09-29	Roehm Gmbh	Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
GB9316221D0 (en) *	1993-08-05	1993-09-22	Zeneca Ltd	Production of polymer emulsions
DE4402666A1 (de)	1994-01-29	1995-08-03	Roehm Gmbh	Verfahren zum kurzzeitigen Behandeln einer Kunststoffschmelze mit einem flüssigen Behandlungsmittel und dabei hergestellter thermoplastischer Kunststoff
DE9414065U1 (de) *	1994-08-31	1994-11-03	Röhm GmbH & Co. KG, 64293 Darmstadt	Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen
DE9414066U1 (de)	1994-08-31	1994-11-03	Röhm GmbH & Co. KG, 64293 Darmstadt	Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform
DE19544562B4 (de)	1995-11-30	2004-05-27	Röhm GmbH & Co. KG	Verfahren zur Herstellung von Poly(meth)acrylimiden mit bei thermischer Belastung verbesserter Farbstabilität und daraus erhältliche Formkörper
DE19633967A1 (de) *	1996-08-22	1998-02-26	Basf Ag	Herstellung hochkonzentrierter Haftklebstoffdispersionen und deren Verwendung
DE19653605C2 (de)	1996-12-20	2002-11-28	Roehm Gmbh	Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems
DE19653606A1 (de)	1996-12-20	1998-06-25	Roehm Gmbh	Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher
DE19704293A1 (de)	1997-02-05	1998-08-06	Basf Ag	Zahnprothesenhaftmittel
DE19718597C1 (de)	1997-05-02	1999-01-07	Roehm Gmbh	Zweistufiges Verfahren zur Entwässerung von Kunststoffdispersionen
EP2138191A1 (de) *	1998-01-05	2009-12-30	University Of Washington	Erhöhter Transport unter Benutzung membranzerstörender Stoffe
DE19809719A1 (de) *	1998-03-06	1999-09-09	Roehm Gmbh	Wäßrige Dispersion geeignet zur Herstellung von Überzugs- und Bindemitteln für feste orale Arzneiformen
DE19918435A1 (de) *	1998-07-23	2000-01-27	Roehm Gmbh	Überzugs- und Bindemittel für orale oder dermale Arzneiformen
JP2002526294A (ja)	1998-09-18	2002-08-20	レームゲゼルシヤフトミツトベシユレンクテルハフツングウントコンパニーコマンディートゲゼルシャフト	情報担体ディスク生成形体のための成形工具
DE19845358A1 (de)	1998-10-02	2000-04-06	Roehm Gmbh	Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
DE10220470A1 (de)	2002-04-30	2003-11-20	Roehm Gmbh	ph-sensitives Polymer
DE19958007A1 (de)	1999-12-02	2001-06-07	Roehm Gmbh	Spritzgußverfahren für (Meth)acrylat-Copolymere mit teritiären Ammoniumgruppen
DE19961334A1 (de)	1999-12-17	2001-06-21	Roehm Gmbh	Spritzgußverfahren für neutrale und säuregruppenhaltige (Meth)acrylat-Copolymere
US6420473B1 (en) *	2000-02-10	2002-07-16	Bpsi Holdings, Inc.	Acrylic enteric coating compositions
US6627223B2 (en) *	2000-02-11	2003-09-30	Eurand Pharmaceuticals Ltd.	Timed pulsatile drug delivery systems
DE10011447A1 (de) *	2000-03-10	2001-09-20	Roehm Gmbh	Dispersion mit nichtionischem Emulgator
DE10013029A1 (de)	2000-03-17	2001-09-20	Roehm Gmbh	Mehrschichtige Arzneiform für die Colonfreigabe
DE10065492A1 (de)	2000-12-28	2003-06-26	Roehm Gmbh	Diffus ausgestattete Formmassen und hieraus erhältliche Formkörper
WO2002060417A1 (de)	2001-01-29	2002-08-08	Röhm GmbH & Co. KG	Lagerstabiles haft- und bindemittel für pharmazeutische anwendungen
SK287902B6 (sk)	2001-01-31	2012-03-02	Evonik Rohm Gmbh	Multiparticulate drug form and method for the preparation thereof
DE10127134A1 (de)	2001-06-05	2002-12-12	Roehm Gmbh	verfahren zur Herstellung von Formkörpern aus (Meth)acrylat-Copolymeren mittels Spritzguß
DE10208335A1 (de)	2002-02-27	2003-09-04	Roehm Gmbh	Arzneiform und Verfahren zu ihrer Herstellung
DE10214002A1 (de)	2002-03-27	2003-10-09	Roehm Gmbh	Pharmazeutische Formulierung für den Wirkstoff Budesonid
MXPA04010956A (es)	2003-01-30	2005-01-25	Roehm Gmbh	Forma de dosis farmaceutica y metodo para la produccion de la misma.

2002
- 2002-05-07 DE DE10220470A patent/DE10220470A1/de not_active Withdrawn
- 2002-10-22 ES ES02785268T patent/ES2386422T3/es not_active Expired - Lifetime
- 2002-10-22 CA CA2480273A patent/CA2480273C/en not_active Expired - Lifetime
- 2002-10-22 WO PCT/EP2002/011791 patent/WO2003092732A1/en not_active Ceased
- 2002-10-22 IL IL16358402A patent/IL163584A0/xx unknown
- 2002-10-22 JP JP2004500915A patent/JP5021160B2/ja not_active Expired - Lifetime
- 2002-10-22 BR BRPI0215731A patent/BRPI0215731B8/pt not_active IP Right Cessation
- 2002-10-22 AU AU2002350592A patent/AU2002350592A1/en not_active Abandoned
- 2002-10-22 US US10/510,371 patent/US7553918B2/en not_active Expired - Lifetime
- 2002-10-22 KR KR1020047017419A patent/KR20050025164A/ko not_active Ceased
- 2002-10-22 EP EP02785268A patent/EP1499358B1/de not_active Expired - Lifetime
- 2002-10-22 AT AT02785268T patent/ATE553780T1/de active
2004
- 2004-08-17 IL IL163584A patent/IL163584A/en active IP Right Grant
2006
- 2006-06-28 US US11/476,182 patent/US7879966B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2480273C (en)	2011-03-22
CA2480273A1 (en)	2003-11-13
ES2386422T3 (es)	2012-08-20
AU2002350592A8 (en)	2003-11-17
EP1499358A1 (de)	2005-01-26
US20060281887A1 (en)	2006-12-14
US20050154165A1 (en)	2005-07-14
JP5021160B2 (ja)	2012-09-05
IL163584A0 (en)	2005-12-18
BRPI0215731B1 (pt)	2018-09-18
JP2005531649A (ja)	2005-10-20
KR20050025164A (ko)	2005-03-11
WO2003092732A1 (en)	2003-11-13
US7553918B2 (en)	2009-06-30
DE10220470A1 (de)	2003-11-20
AU2002350592A1 (en)	2003-11-17
IL163584A (en)	2012-10-31
BR0215731A (pt)	2005-02-09
US7879966B2 (en)	2011-02-01
BRPI0215731B8 (pt)	2021-05-25
EP1499358B1 (de)	2012-04-18

Publication	Publication Date	Title
BR0215731A (pt)	2005-02-09	Polìmero sensìvel ao ph
CY1112687T1 (el)	2016-02-10	Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες
DE69907137D1 (de)	2003-05-28	Autoklavierbare pharmazeutische zusammensetzungen mit komplexbildner
NO20025954D0 (no)	2002-12-11	Glykopeptidfosfonatderivater
FI20050932A7 (fi)	2005-11-18	Heterobifunktionaaliset polymeeriset biokonjugaatit
BR0209242A (pt)	2004-06-15	Aminopolidiorganossiloxanos amido-funcionais
EP1472230A4 (de)	2005-07-06	Ansamycine mit verbesserten pharmakologischen und biologischen eigenschaften
DK0960107T3 (da)	2003-02-10	6-Thiosubstituerede paclitaxeler
BR0116452A (pt)	2003-09-30	Composto, composição farmacêutica, uso de um composto
ITTO20010005A0 (it)	2001-01-09	Formulazione farmaceutica.
ATE312843T1 (de)	2005-12-15	Neues cyclosporin mit verbesserter wirkung
ATE445386T1 (de)	2009-10-15	Polymerische parfümpartikel
DE60007095D1 (de)	2004-01-22	Calanolide zur hemmung von btk
ATE231872T1 (de)	2003-02-15	Thiazolopyrimidinderivate
ES1042687Y (es)	2000-02-01	Dispositivo dispensador de articulos aplanados.
BR0106649B1 (pt)	2011-11-29	composição fertilizante contendo enxofre.
DE10084671T1 (de)	2002-06-06	Pharmazeutische Zusammensetzungen
ATE240303T1 (de)	2003-05-15	1,2,4-triazol-3-thion verbindungen
IT1311921B1 (it)	2002-03-20	Composti farmaceutici.
BRPI0417950A (pt)	2007-04-17	composições farmacêuticas
EA200400670A1 (ru)	2004-10-28	Фармацевтические композиции, содержащие 3,4-пропинопергидропурины, и их применение для блокирования нейронной передачи
ITMI20001848A0 (it)	2000-08-08	Faramaci per l'incontinenza.
ATE293126T1 (de)	2005-04-15	Cyclische hexapeptidderivate
DE602004028236D1 (de)	2010-09-02	Pharmazeutische zusammensetzung enthaltend glucan aus mikroalgen
EP1051141A4 (de)	2001-05-23	Insulin haltige pharmazeutische zusammensetzungen enthaltend einen amylinagonisten